BioNTech SE (ETR:22UA)
Germany · Delayed Price · Currency is EUR 86.15
+0.65 (0.76%)
Jan 9, 2026, 4:00 PM EST
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €21.54 billion as of January 12, 2026. Its market cap has decreased by -17.70% in one year.
Market Cap
21.54B
Enterprise Value
7.13B
Revenue
3.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
€86.15
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 21.54B, an increase of 691.73%. That is a compound annual growth rate of 39.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 21.54B | 10.48% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.61B |
| Siemens Healthineers AG | 51.92B |
| Bayer Aktiengesellschaft | 38.29B |
| Fresenius SE & Co. KGaA | 27.63B |
| Sartorius Aktiengesellschaft | 15.76B |
| Fresenius Medical Care AG | 11.04B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 3.61B |